First Description of Two Sequence Type 2 Acinetobacter baumannii Isolates Carrying OXA-23 Carbapenemase in Pagellus acarne Fished from the Mediterranean Sea near Bejaia, Algeria

Antimicrobial Agents and Chemotherapy
Soumia BrahmiCatherine Dunyach-Remy

Abstract

To determine the occurrence of carbapenem-resistantAcinetobacter baumanniiin fish fished from the Mediterranean Sea near the Bejaia coast (Algeria), we studied 300 gills and gut samples that had been randomly and prospectively collected during 1 year. After screening on selective agar media, using PCR arrays and whole-genome sequencing, we identified for the first time two OXA-23-producingA. baumanniistrains belonging to the widespread sequence type 2 (ST2)/international clone II and harboring aminoglycoside-modifying enzymes [aac(6')-Ib andaac(3')-I genes].

References

Apr 12, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·K LeeJ H Yum
Mar 28, 2006·International Journal of Antimicrobial Agents·Neil WoodfordDavid M Livermore
Jul 6, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J F TurtonT L Pitt
May 21, 2008·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Xiao-Lin YinLin Wei
Sep 23, 2009·Antimicrobial Agents and Chemotherapy·Paul G HigginsHarald Seifert
Dec 25, 2009·Emerging Infectious Diseases·Pauline D MugnierPatrice Nordmann
Jul 9, 2010·BMC Infectious Diseases·Lemuel L DentRobert B Hulette
Nov 25, 2011·International Journal of Antimicrobial Agents·Marie Kempf, Jean-Marc Rolain
Mar 2, 2012·Emerging Infectious Diseases·Laurent PoirelPatrice Nordmann
May 26, 2012·Journal of Medical Microbiology·Sofiane BakourJean-Marc Rolain
Aug 9, 2012·The Journal of Antimicrobial Chemotherapy·Annemieke SmetFreddy Haesebrouck
Nov 7, 2012·International Journal of Antimicrobial Agents·Raffaele ZarrilliAthanassios Tsakris
Jan 16, 2013·Trends in Microbiology·Meritxell García-QuintanillaMichael J McConnell
Feb 27, 2013·Antimicrobial Agents and Chemotherapy·Paul G HigginsHarald Seifert
Mar 2, 2013·The Journal of Antimicrobial Chemotherapy·Wan-Jiang ZhangSiguo Liu
Apr 23, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Esma MesliJean-Marc Rolain
Jun 24, 2014·BioMed Research International·Nassima DjahmiJean-Philippe Lavigne

❮ Previous
Next ❯

Citations

Nov 12, 2016·Journal of Global Antimicrobial Resistance·Wafaa ChaalalJean-Marc Rolain
Aug 12, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Taous BachiriAbdelaziz Touati
May 9, 2018·International Journal of Environmental Health Research·Svjetlana DekićJasna Hrenović
Nov 2, 2017·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Nicole RoschanskiUwe Roesler
Nov 2, 2016·Antimicrobial Agents and Chemotherapy·Agnese LupoJean-Yves Madec
Jan 15, 2019·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Khadidja YousfiSadjia Bekal
May 6, 2019·Microbial Ecology·Houssem Ben YahiaKarim Ben Slama
Oct 11, 2019·Microbial Genomics·Mohammad Hamidian, Steven J Nigro
Jan 6, 2021·Food Microbiology·Ana CarvalheiraPaula Teixeira
Dec 3, 2020·Infection and Drug Resistance·Olfa DziriChedly Chouchani
Aug 14, 2018·Microbiology Spectrum·Agnese LupoJean-Yves Madec
Nov 10, 2021·Annals of the New York Academy of Sciences·Suzan Mohammed RaghebJohn Osei Sekyere

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.